Cardiogenic shock after 5-fluorouracil administration: a case report and literature review
Lowie Vanoverbeke, Holvoet Wouter, D’Heygere François, Elegeert Ivan, Diego Araiza-Garaygordobil, Maria Concetta Pastore, Franca Morselli · 2023
Read Cardiogenic shock after 5-fluorouracil administration: a case report and literature review by Lowie Vanoverbeke, Holvoet Wouter, D’Heygere François, Elegeert Ivan, Diego Araiza-Garaygordobil, Maria Concetta Pastore, Franca Morselli (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10720692.txt.
Description
Lowie Vanoverbeke and co-authors review heart shock after a chemotherapy drug in a 2023 case paper. The drug 5-fluorouracil rarely triggers cardiogenic shock, where the heart suddenly cannot pump. Little guidance exists for that emergency. Their patient also developed dangerous heart rhythm disturbances.
Standard pressure and pump supporting drugs came first. A balloon pump inside the aorta added support. Instability persisted, so two mechanical systems were implanted together. A membrane oxygenation circuit and a small pump bridged the patient toward recovery. Heart function then returned fully, and the devices were removed. The authors survey the sparse literature on this toxicity. Their message is that aggressive mechanical support can buy the heart time to heal.
Catalog record
| CREATOR | Lowie Vanoverbeke, Holvoet Wouter, D’Heygere François, Elegeert Ivan, Diego Araiza-Garaygordobil, Maria Concetta Pastore, Franca Morselli |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |